{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T18:42:57Z","timestamp":1760380977719,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.euroneuro.2023.10.007","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T03:15:05Z","timestamp":1702523705000},"page":"1-2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Can antipsychotics prevent transition to psychosis in high-risk population?"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9851-3271","authenticated-orcid":false,"given":"Pavel","family":"Mohr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2023.10.007_bib0001","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fpsyt.2018.00187","article-title":"Efficacy and acceptability of interventions for attenuated positive psychotic symptoms in individuals at clinical high risk of psychosis: a network meta-analysis","volume":"9","author":"Davies","year":"2018","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.10.007_bib0002","doi-asserted-by":"crossref","first-page":"17r12053","DOI":"10.4088\/JCP.17r12053","article-title":"Interventions and transition in youth at risk of psychosis: a systematic review and meta-analyses","volume":"81","author":"Devoe","year":"2020","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.euroneuro.2023.10.007_bib0003","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3389\/fpsyt.2019.00764","article-title":"Preventive treatments for psychosis: umbrella review (just the evidence)","volume":"10","author":"Fusar-Poli","year":"2019","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.10.007_bib0004","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.euroneuro.2023.03.001","article-title":"The elephant in the room: medication as confounder","volume":"71","author":"Ilzarbe","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2023.10.007_bib0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jamapsychiatry.2016.2902","article-title":"Effect of \u03c9-3 polyunsaturated fatty acids in young people at ultrahigh risk for psychotic disorders: the NEURAPRO randomized clinical trial","volume":"74","author":"McGorry","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.10.007_bib0006","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.eurpsy.2018.06.007","article-title":"Value of schizophrenia treatment I: the patient journey","volume":"53","author":"Mohr","year":"2018","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.10.007_bib0007","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1017\/S0033291720004237","article-title":"Meta-analyzing the prevalence and prognostic effect of antipsychotic exposure in clinical high-risk (CHR): when things are not what they seem","volume":"50","author":"Raballo","year":"2020","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2023.10.007_bib0008","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41398-023-02405-6","article-title":"The temporal dynamics of transition to psychosis in individuals at clinical high-risk (CHR-P) shows negative prognostic effects of baseline antipsychotic exposure: a meta-analysis","volume":"13","author":"Raballo","year":"2023","journal-title":"Transl. Psychiatry."},{"key":"10.1016\/j.euroneuro.2023.10.007_bib0009","doi-asserted-by":"crossref","first-page":"14092","DOI":"10.4088\/JCP.21m14092","article-title":"Antipsychotic exposure in clinical high risk of psychosis: empirical insights from a large cohort study","volume":"83","author":"Zeng","year":"2022","journal-title":"J. Clin. Psychiatry"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X2300706X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X2300706X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T18:06:58Z","timestamp":1760378818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X2300706X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":9,"alternative-id":["S0924977X2300706X"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2023.10.007","relation":{},"ISSN":["0924-977X"],"issn-type":[{"type":"print","value":"0924-977X"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can antipsychotics prevent transition to psychosis in high-risk population?","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2023.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}